US Stock MarketDetailed Quotes
NVS Novartis AG
- 106.450
- -0.630-0.59%
Close Nov 8 16:00 ET
- 106.590
- +0.140+0.13%
Post 20:01 ET
212.82BMarket Cap12.49P/E (TTM)
106.690High106.130Low1.18MVolume106.610Open107.080Pre Close125.23MTurnover0.06%Turnover Ratio14.99P/E (Static)2.00BShares120.92052wk High4.91P/B203.10BFloat Cap89.52452wk Low3.78Dividend TTM1.91BShs Float120.920Historical High3.55%Div YieldTTM0.52%Amplitude7.088Historical Low106.407Avg Price1Lot Size
Novartis AG Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 18.51%6.29B | 38.61%4.88B | -20.58%2.27B | 9.06%14.22B | -32.40%2.55B | 24.07%5.3B | -5.58%3.52B | 72.95%2.85B | -2.44%13.04B | 73.00%3.77B |
| Net income from continuing operations | 110.51%3.19B | 42.93%3.25B | 25.02%2.69B | 41.71%8.57B | 100.61%2.64B | 13.76%1.51B | 33.98%2.27B | -3.11%2.15B | -73.59%6.05B | -91.34%1.32B |
| Operating gains losses | -156.45%-159M | -15.91%74M | 132.89%99M | 43.77%-167M | 186.29%107M | -520.00%-62M | 161.11%88M | -296.05%-301M | 98.14%-297M | 99.15%-124M |
| Depreciation and amortization | -36.84%1.97B | -31.97%1.16B | -29.73%1.31B | 23.45%8.28B | -12.84%1.59B | 62.45%3.11B | -5.22%1.71B | 33.10%1.87B | 19.80%6.71B | 81.66%1.82B |
| Deferred tax | 412.82%200M | 47.64%595M | 19.19%441M | -51.15%551M | -202.76%-261M | -84.82%39M | 16.14%403M | -17.78%370M | -30.58%1.13B | 68.21%254M |
| Other non cash items | 182.00%41M | -71.54%-223M | 65.18%-180M | -26,066.67%-785M | 53.23%-87M | -134.01%-50M | -402.33%-130M | -10,240.00%-517M | 98.56%-3M | -745.45%-186M |
| Change In working capital | -11.71%1.04B | 332.73%238M | -63.30%-1.99B | 53.64%-369M | -184.21%-384M | 163.53%1.18B | 201.85%55M | 39.43%-1.22B | -990.41%-796M | -47.10%456M |
| -Change in receivables | 380.34%328M | -12.08%-501M | -31.43%-920M | -278.84%-1.5B | -156.07%-240M | 13.97%-117M | -8.23%-447M | -41.13%-700M | -12.78%-397M | 100.94%428M |
| -Change in inventory | 372.73%90M | 90.27%-18M | 64.54%-128M | 2.50%-546M | 171.74%33M | 74.42%-33M | 4.64%-185M | 15.06%-361M | -449.02%-560M | -155.56%-46M |
| -Change in payables and accrued expense | 40.76%-109M | -294.52%-142M | -1,673.08%-409M | 364.64%479M | 291.67%564M | -52.07%-184M | 563.64%73M | 118.18%26M | -63.06%-181M | -68.83%144M |
| -Change in other current assets | -425.00%-52M | -1,266.67%-105M | -149.54%-272M | -48.81%-125M | -2,150.00%-41M | -87.40%16M | -87.14%9M | 69.97%-109M | 53.07%-84M | -99.27%2M |
| -Change in other current liabilities | -47.66%783M | 65.95%1B | -251.35%-260M | 211.50%1.33B | -872.22%-700M | 111.90%1.5B | 28.18%605M | 87.33%-74M | -36.51%426M | -4.35%-72M |
| Cash from discontinued investing activities | -80.12%238M | 0 | -83.41%74M | 59M | 105M | -29.84%1.2B | 343M | |||
| Operating cash flow | 16.88%6.29B | 36.33%4.88B | -23.40%2.27B | 1.56%14.46B | -38.04%2.55B | 13.92%5.38B | -4.77%3.58B | 79.32%2.96B | -5.54%14.24B | 5.84%4.11B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 81.34%-374M | -234.06%-3.21B | -108.40%-899M | 252.89%6.72B | 22.52%-1.02B | -137.75%-2B | 91.74%-960M | 14.31%10.71B | -61.12%1.9B | -125.11%-1.32B |
| Net PPE purchase and sale | -52.38%-320M | -0.90%-223M | -50.67%-226M | -8.58%-823M | -18.63%-242M | -4.48%-210M | 9.43%-221M | 33.04%-150M | 11.35%-758M | -98.06%-204M |
| Net intangibles purchase and sale | -132.48%-455M | 33.43%-448M | -920.88%-929M | 122.72%262M | -95.31%-375M | 664.92%1.4B | -238.19%-673M | 83.02%-91M | -43.41%-1.15B | 51.02%-192M |
| Net business purchase and sale | 98.17%-63M | -3,773.26%-3.33B | -911.54%-263M | -313.08%-3.57B | -22.22%-11M | -57,533.33%-3.45B | -40.98%-86M | 96.90%-26M | -104.22%-864M | -100.04%-9M |
| Net investment purchase and sale | 84.46%463M | 3,875.00%795M | -95.27%519M | 131.82%10.85B | 56.89%-394M | -95.64%251M | 100.18%20M | 0.07%10.97B | 133.78%4.68B | 93.88%-914M |
| Net other investing changes | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 98.18%-1M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 83.09%-374M | -204.56%-3.21B | -108.46%-899M | 281.20%5.6B | -19.97%-1.76B | -142.55%-2.21B | 90.94%-1.05B | 13.41%10.62B | -65.11%1.47B | -132.15%-1.47B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 91.13%-382M | 15.03%-3.2B | 42.60%-5.16B | 15.07%-17.56B | 87.90%-496M | 9.33%-4.31B | -63.60%-3.77B | 5.58%-9B | -26.96%-20.68B | -25.08%-4.1B |
| Net issuance payments of debt | 192.83%2.51B | 207.62%833M | 23.58%1.15B | 25.15%-1.94B | 148.41%610M | -31.07%-2.7B | -333.84%-774M | 130.94%933M | 56.82%-2.59B | 59.50%-1.26B |
| Net common stock issuance | -75.63%-2.85B | 45.35%-1.62B | 61.92%-1.1B | 18.15%-8.72B | 53.29%-1.25B | 40.21%-1.63B | -8.95%-2.96B | -13.53%-2.89B | -248.45%-10.65B | -1,709.46%-2.68B |
| Cash dividends paid | ---- | ---2.42B | 28.23%-5.21B | 3.34%-7.26B | --0 | ---- | ---- | 3.34%-7.26B | -1.87%-7.51B | --0 |
| Proceeds from stock option exercised by employees | --5M | --25M | ---- | 53.00%153M | ---5M | ---- | ---- | 69.15%159M | 88.68%100M | --0 |
| Net other financing activities | -286.96%-43M | 28.57%-25M | -120.75%-11M | 605.26%192M | 193.17%150M | -28.13%23M | -146.67%-35M | 140.91%53M | -155.07%-38M | -794.44%-161M |
| Cash from discontinued financing activities | 2,661.34%3.29B | -205.71%-111M | 31,481.82%3.47B | 129M | -206M | 357.69%119M | 105M | |||
| Financing cash flow | 54.09%-382M | 12.02%-3.2B | 43.88%-5.16B | 30.56%-14.28B | 84.80%-607M | 82.44%-832M | -57.99%-3.64B | 3.42%-9.2B | -26.43%-20.56B | -22.85%-3.99B |
| Net cash flow | ||||||||||
| Beginning cash position | -27.40%7.9B | -21.09%9.47B | 78.17%13.39B | -39.41%7.52B | 42.16%12.41B | 200.28%10.89B | -13.37%12B | -39.41%7.52B | 28.46%12.41B | 21.01%8.73B |
| Current changes in cash | 228.00%5.53B | -37.52%-1.53B | -186.79%-3.8B | 218.90%5.78B | 161.33%828M | -67.46%1.69B | 89.05%-1.11B | 194.48%4.38B | -261.13%-4.86B | -125.98%-1.35B |
| Effect of exchange rate changes | 206.02%176M | -3,300.00%-34M | -217.76%-126M | 412.50%100M | 13.48%160M | -107.50%-166M | 98.08%-1M | 360.98%107M | 87.97%-32M | --141M |
| End cash Position | 9.71%13.61B | -27.40%7.9B | -21.09%9.47B | 78.17%13.39B | 78.17%13.39B | 42.16%12.41B | 200.28%10.89B | -13.37%12B | -39.41%7.52B | -39.41%7.52B |
| Free cash flow | 16.87%5.49B | 54.85%4.15B | -56.81%1.11B | -2.43%11.71B | -51.18%1.76B | 10.50%4.7B | -15.57%2.68B | 225.06%2.57B | -4.14%12B | 8.76%3.61B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
